Generate Biomedicines, Inc.

NASDAQ:GENB

Asset Management

Financial Services
$10.38 +0.91%

+$0.13 today

Market cap
$1.34B
Beta
0.19
P/E (TTM)
-3.5
EPS (TTM)
-$4.06
52W Low $11.00High $16.75

Volume 1.05M

Average 0.55M

Balance Sheet

Inspect the capital base behind the business.

Assets

$330.18M

FY 2025 · Annual

-36.3% YoY

Liabilities

$953.38M

FY 2025 · Annual

+0.0% YoY

Equity

-$623.20M

FY 2025 · Annual

Balance Sheet

USD

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$160.6M
Short-term Investments$356.1M
Other Current$18.7M
Total Current Assets$535.4M
PP&E (Net)$85.6M
Other Non-current$4.7M
Total Non-current Assets$90.3M
Total Assets$625.7M

Analysis

Selected assets total $625.7M for Latest. The largest visible component is Short-term Investments at $356.1M, about 56.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
SC 13GSC 13G filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
4Statement of changes in beneficial ownershipSep 3, 2026

How much cash does GENB have?

Generate Biomedicines, Inc. (GENB) reported $121.65M in cash and equivalents in fiscal 2025.

How much debt does GENB carry?

Generate Biomedicines, Inc. (GENB) reported $68.53M of total debt, with net debt of -$53.12M.